Insider · CIK 0001342826
Stanley C Erck
Files at MXCT (MAXCYTE, INC.). First filing Nov 5, 2024, latest Aug 13, 2025.
In brief
Stanley C Erck files SEC Form 4 as director at MXCT (MAXCYTE, INC.). Since Nov 5, 2024, Stanley C Erck has reported 1 open-market buy worth $137k and 1 open-market sell worth $177k, the latest filed on Aug 13, 2025.
A track record needs three past buys with six months of prices behind them; Stanley C Erck has 0, so none is measured yet.
The newest scored trade: bought $137k of MXCT on Aug 13, 2025, filed Aug 13, 2025, scored 65 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MXCT: MAXCYTE, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | MAXCYTE, INC. | $137k 100,000 shares | +34% | +9% from low-73% from high | |
| 5Weak | MAXCYTE, INC. | $177k 47,689 shares | -15% | - |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | MXCT MAXCYTE, INC. | AGrant or award Common Stock | +30,421 | $0.00 | $0 | 428,749 | Jun 22, 2026 |
| Jun 17, 2026 | MXCT MAXCYTE, INC. | AGrant or award Stock Option (right to buy)derivative | +49,579 | $0.00 | $0 | 49,579 | Jun 22, 2026 |
| Aug 13, 2025 | MXCT MAXCYTE, INC. | POpen-market purchase Common Stock | +100,000 | $1.37 | $137k | 398,328 | Aug 13, 2025 |
| Jun 18, 2025 | MXCT MAXCYTE, INC. | AGrant or award Common Stock | +29,210 | $0.00 | $0 | 298,328 | Jun 23, 2025 |
| Jun 18, 2025 | MXCT MAXCYTE, INC. | AGrant or award Stock Option (right to buy)derivative | +50,790 | $0.00 | $0 | 50,790 | Jun 23, 2025 |
| Nov 1, 2024 | MXCT MAXCYTE, INC. | MOption exercise Common Stock10b5-1 | +47,689 | $0.04 | $1,908 | 316,807 | Nov 5, 2024 |
| Nov 1, 2024 | MXCT MAXCYTE, INC. | SOpen-market sale Common Stock10b5-1 | -47,689 | $3.72 | $177k | 269,118 | Nov 5, 2024 |
| Nov 1, 2024 | MXCT MAXCYTE, INC. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -47,689 | $0.00 | $0 | 0 | Nov 5, 2024 |
Questions about Stanley C Erck
Answered from the filings on this page, as of the latest one.
Is Stanley C Erck buying or selling?
Not in the last 12 months. Stanley C Erck's latest open-market trade on SEC Form 4 was bought $137k of MXCT on Aug 13, 2025.
How did Stanley C Erck's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stanley C Erck has 0.
Where does Stanley C Erck file Form 4?
Stanley C Erck has filed Form 4 at MXCT (MAXCYTE, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.